Fenofibrate (Lipidil Ez, Aa-Feno-Super) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Sep 4, 2026
Also sold as: Lipidil Ez, Aa-Feno-Super, Aa-Feno-Micro, Lipidil Supra
Some Fenofibrate products are in shortage in Canada (1 of 22 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Sep 11, 2026.
A fibrate used to lower high triglycerides and cholesterol.
Products affected
1 / 22
In shortage since
Sep 3, 2026
Est. full return
Sep 11, 2026
Reports on file
73
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
SPC-FENOFIBRATE E
145MG · TABLET · SUN PHARMA CANADA INC
DIN 02454696 · since Sep 3, 2026, est. end Sep 11, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ FENOFIBRATE E
48.0MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02390698 · ended Jun 22, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ FENOFIBRATE E
48.0MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02390698 · ended Dec 12, 2025 · Delay in shipping of the drug.
Resolved
LIPIDIL EZ
145MG · TABLET · BGP PHARMA ULC
DIN 02269082 · ended Jul 30, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ FENOFIBRATE E
145.0MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02390701 · ended May 19, 2025 · Delay in shipping of the drug.
Resolved
SANDOZ FENOFIBRATE E
145.0MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02390701 · ended Mar 24, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ FENOFIBRATE E
48.0MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02390698 · ended Mar 24, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-FENOFIBRATE E
145MG · TABLET · SUN PHARMA CANADA INC
DIN 02454696 · ended Jan 30, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ FENOFIBRATE E
48.0MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02390698 · ended Jan 27, 2025 · Demand increase for the drug.
Resolved
AA-FENO-SUPER
160MG · TABLET · AA PHARMA INC
DIN 02246860 · ended Sep 4, 2024 · Disruption of the manufacture of the drug.
Resolved
AA-FENO-SUPER
160MG · TABLET · AA PHARMA INC
DIN 02246860 · ended Mar 19, 2024 · Disruption of the manufacture of the drug.
Resolved
AA-FENO-SUPER
100MG · TABLET · AA PHARMA INC
DIN 02246859 · ended Mar 18, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Fenofibrate is currently affected by an active shortage report filed with Health Canada by SUN PHARMA CANADA INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Fenofibrate is classified under “LIPID MODIFYING AGENTS, PLAIN” (ATC C10AB).
Recent changes
Sep 4, 2026
New report filed
Common questions
What is Fenofibrate used for?
A fibrate used to lower high triglycerides and cholesterol.
When will Fenofibrate be back in stock in Canada?
The latest manufacturer estimate is Sep 11, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Fenofibrate in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.